Program

Day 1 September 15 (Tue)

Session

Market Access and Commercialization Strategies Across European Countries After MDR

This session examines country‑specific market differences and strategic approaches required for entering the European market after MDR.
It also explores reimbursement, procurement, and distribution pathways that vary by country, along with the practical considerations Korean medical device companies should prepare for when entering the Polish market.

Time Title Speaker
09:30 – 09:35 (05’) Opening Remarks Ko Sang‑Baek
KHIDI
President
09:35 – 09:40 (05’) Congratulatory Remarks Sung Chang‑Hyun
Health Industry Policy Bureau, MOHW
Director-General
09:40 – 10:40 (60’) Understanding Europe Beyond MDR Drazen Jese
Hedgehog Consulting
Managing Partner
10:40 – 10:50 (10’) Break
10:50 – 11:50 (60’) From MDR Compliance to Market Entry in Poland Adam Sobantka
Global Certification Body
President of the Board
11:50 – 12:20 (30’) Q&A

Speakers

You can click on each speaker to view their Professional Experience and Abstract.

  • Drazen Jese
    09:40 - 10:40 Understanding Europe Beyond MDR
    Drazen Jese
    Hedgehog Consulting
    Managing Partner
    Close
    Drazen Jese
    Drazen Jese

    Hedgehog Consulting
    Managing Partner

    09:40 - 10:40
    • Professional Experience

      He is a medical device and pharmaceutical industry expert with an MPharm and an MBA, and the Founder and Managing Partner of Hedgehog Consulting. His firm supports market entry strategies, market and competitive landscape analysis, market access and reimbursement, and overall commercialization for companies targeting the European and U.S. markets. He has extensive global business experience in the medical device and pharmaceutical sectors and is also an active investor in numerous startups and ventures.

    • Abstract

      Although CE marking under the EU MDR is a critical requirement for entering the European market, the actual processes of purchasing and adoption vary significantly by country. This presentation will examine country specific market needs, adoption barriers in clinical settings, reimbursement pathways, payers, purchasing and decision making stakeholders, and end users.

      Drawing on real world cases, the session will also outline how to select target countries and develop tailored market entry and commercialization strategies. These strategies will consider customer needs, value propositions, pricing, positioning, and distribution approaches for each market.

  • Adam Sobantka
    10:50 – 11:50 From MDR Compliance to Market Entry in Poland
    Adam Sobantka
    Global Certification Body
    President of the Board
    Close
    Adam Sobantka
    Adam Sobantka

    Global Certification Body
    President of the Board

    10:50 – 11:50
    • Professional Experience

      He is the Co‑Founder and CEO of Global Certification Body, an EU Notified Body for medical devices. Over the past 16 years, he has served as CEO of the CRO Pure Clinical, a Notified Body expert, and a technical specialist, auditor, and certification decision-maker for the European Commission and various governmental authorities. He is also active in academia as a lecturer and has authored multiple publications related to the medical device industry.

    • Abstract

      This presentation explores the actual market entry process for medical devices in Poland following MDR compliance and CE marking. It will cover the role of the Polish regulatory authority URPL, local requirements such as language obligations, market entry pathways, hospital public procurement procedures, and the two reimbursement routes. The session will also explain the roles of key institutions including AOTMiT, NFZ, URPL, and the Ministry of Health.

      In addition, the presentation will compare Poland’s system with those of Germany, Italy, France, and Spain, and highlight common challenges and key considerations that foreign manufacturers frequently encounter when entering the Polish market, supported by practical real world examples.